Integrating data to find new treatments for Alzheimer's disease
TREAT AD Bioinformatics Core
This study is looking at different genetic and biological information to find new ways to treat Alzheimer's disease, aiming to help patients by creating a score that shows their genetic risk and could lead to better treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10954113 on NIH RePORTER |
What this research studies
This research focuses on combining various types of genetic and biological data to identify and validate new protein targets for treating Alzheimer's disease. By analyzing information from genome-wide studies, medical genetics, and brain samples, the project aims to create a comprehensive score that reflects the genetic risk factors associated with Alzheimer's. The goal is to develop a data-driven approach that can lead to innovative therapeutic strategies for patients affected by this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease or those diagnosed with Alzheimer's or related dementias.
Not a fit: Patients with forms of dementia unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel treatments that specifically target the biological mechanisms underlying Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in using integrated data approaches to identify therapeutic targets in Alzheimer's disease, suggesting that this methodology could be effective.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Levey, Allan I — Emory University
- Study coordinator: Levey, Allan I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.